#Canada #Aurora Cannabis #Edmonton #medical cannabis #Growth Conference

Aurora Cannabis at Canaccord Genuity 45th Annual Growth Conference

Aurora Cannabis Inc., a renowned leader in the global medical cannabis industry, is scheduled to participate in the Canaccord Genuity 45th Annual Growth Conference in Boston, Massachusetts. On August 13th, 2025, Simona King, the Chief Financial Officer of Aurora, will engage in a fireside chat starting at 1:30 PM EST, followed by one-on-one meetings with investors throughout the day. This conference presents a vital opportunity for Aurora to discuss its strategic direction, recent developments, and future growth opportunities within the burgeoning medical cannabis market.

Key Discussion Points

During her presentation, Simona will delve into Aurora's recent milestones and strategic initiatives that define its path in the competitive landscape of medical cannabis. As a company committed to innovation, Aurora aims to reinforce its leadership in the sector by focusing on high-quality, science-driven cannabis products that cater to diverse consumer needs across Canadian, European, Australian, and New Zealand markets. The company’s diverse portfolio includes both medical and adult-use cannabis brands, pioneering new standards in product quality and customer satisfaction.

Details of the Conference

• - Date: August 13, 2025
• - Time: 1:30 PM Eastern Standard Time (EST)
• - Webcast: Interested individuals can register to listen to the live audio webcast. The link to the webcast will also be available on Aurora’s Investor Info section on their website.

The company is looking forward to presenting insights into the medical cannabis sector, acknowledging current trends, and discussing the future landscape influenced by regulatory changes, consumer preferences, and market dynamics.

About Aurora Cannabis

Founded and headquartered in Edmonton, Alberta, Aurora Cannabis is dedicated to providing high-quality cannabis options for both medical and recreational consumers. Their adult-use brands, such as Drift and San Rafael '71, highlight their innovative spirit, while their medical brands, including MedReleaf and CanniMed, emphasize their commitment to improving lives through cannabis.

Moreover, Aurora’s controlling interest in Bevo Farms Ltd. aligns with their vision of sustainability and quality in agricultural practices. With an extensive product lineup and an unwavering dedication to scientific advancement, Aurora is poised to continue leading the market as it expands.

Looking Ahead

Aurora's participation at the Canaccord Genuity conference is an essential part of its strategy to inform stakeholders about its projected growth trajectories and the evolving cannabis landscape. As regulations shift and market needs evolve, Aurora is set to adapt and thrive, providing valuable insights to investors and partners alike.

For more detailed information about their brands and initiatives, visit Aurora’s official site. Stay connected by following them on social media platforms like X and LinkedIn.

With its robust framework for innovation and market adaptation, Aurora Cannabis continues to be a significant player in the evolving global cannabis industry. Observers can expect insightful updates and informative discussions from the upcoming conference, shaping the future of medical cannabis.